HuniLife Biotechnology, Inc.
2 clinical trials · Sponsor
◉ Watch HuniLife Biotechnology, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients (NCT07210047) | HuniLife Biotechnology, Inc. | 2025-08-18 |
| A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 (NCT04540770) | HuniLife Biotechnology, Inc. | 2021-08-31 |
Track HuniLife Biotechnology, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.